Personal stories

The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.

The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.

Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.

Tuition assistance with wraparound support like childcare grants enable nursing students to advance their goals and is helping to close healthcare gaps in New Jersey.

Carolina Benitez is passionate about educating her patients and empowering them to manage their own health and make informed health choices.

Nina Raver-Shapira, Ph.D., loves a challenge: The Johnson & Johnson scientist persisted for years to develop an innovative surgical patch that helps stop problematic bleeding during surgery—and she’s also a record-breaking elite athlete. For Women’s Equality Day, find out how she got her start, what achievements she’s most proud of and where she finds inspiration.

Consumer brands including Tylenol, Band-Aid Brand Adhesive Bandages and Johnson’s Baby are owned by Kenvue Inc., which has been an independent publicly traded company since August 2023.

Guillermo Pepe, founder and CEO of Mamotest, elaborates on the opportunity of using AI to expand access to healthcare in new ways, and their unique approach as a tech company that is still human-centric and focused on patient care.